BC Global Opportunities IX LP

13F Holdings History for BridgeBio Oncology Therapeutics, Inc. - Common Stock (BBOT)

Symbol: BBOT on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Ownership: 4.37M shares
Security Ownership: 5.5%

BC Global Opportunities IX LP ownership in BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT)

2025-09-03 - BC Global Opportunities IX LP has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 4.37M shares of BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT). This represents 5.5% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
BC Global Opportunities IX LP	5.5%		$41.3M	4.37M			$9.45	13G	9/4/2025	3 Sep 2025 15:05:41